FMC CORP FMC
NYSE · XNYS · stock · Chemicals & Allied Products
Chart by TradingView
1/9
Piotroski F — financial health
1.37
Altman Z″ — distress risk · grey
-13.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.5B | -$2.2B | $1.3B | -$102.5M | $2.1B |
| 2024 | $4.2B | $341.1M | $1.6B | $668.8M | $4.5B |
| 2023 | $4.5B | $1.3B | $1.8B | -$434.2M | $4.4B |
| 2022 | $5.8B | $736.5M | $2.3B | $517.7M | $3.4B |
| 2021 | $5.0B | $739.6M | $2.2B | $798.5M | $3.1B |
| 2020 | $4.6B | $552.4M | $2.0B | $669.6M | $3.1B |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.37 (grey)
- Working capital / assets 0.124
- Retained earnings / assets 0.43
- EBIT / assets -0.168
- Equity / liabilities 0.272
Source: SEC EDGAR filings · CIK 0000037785 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.